LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation

Abstract EN

Background.

Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies worldwide.

It is characterized by its high invasive and metastatic potential.

Leprecan-like 1 (LEPREL1) has been demonstrated to be downregulated in the HCC tissues in previous proteomics studies.

The present study is aimed at a new understanding of LEPREL1 function in HCC.

Methods.

Quantitative RT-PCR, immunohistochemical analysis, and western blot analysis were used to evaluate the expression of LEPREL1 between the paired HCC tumor and nontumorous tissues.

The biology function of LEPREL1 was investigated by Cell Counting Kit-8 (CCK8) assay and colony formation assay in HepG2 and Bel-7402 cells.

Results.

The levels of LEPREL1 mRNA and protein were significantly lower in the HCC tissues as compared to those of the nontumorous tissues.

Reduced LEPREL1 expression was not associated with conventional clinical parameters of HCC.

Overexpression of LEPREL1 in HepG2 and Bel-7402 cells inhibited cell proliferation (P<0.01) and colony formation (P<0.05).

LEPREL1 suppressed tumor cell proliferation through regulation of the cell cycle by downregulation of cyclins.

Conclusions.

Clinical parameters analysis suggested that LEPREL1 was an independent factor in the development of HCC.

The biology function experiments showed that LEPREL1 might serve as a potential tumor suppressor gene by inhibiting the HCC cell proliferation.